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Abstract: Background and Objectives: The Investigation of Palpitations in the ED (IPED) study showed
that a smartphone-based event recorder increased the number of patients in whom an electrocardio-
gram (ECG) was captured during symptoms over five-fold to more than 55% at 90 days compared to
standard care and concluded that this safe, non-invasive and easy-to-use device should be considered
part of on-going care to all patients presenting acutely with unexplained palpitations or pre-syncope.
This study reports the process of establishing a smartphone palpitation and pre-syncope ambulatory
care Clinic (SPACC) service. Materials and Methods: A clinical standard operating procedure (SOP)
was devised, and funding was secured through a business case for the purchase of 40 AliveCor
devices in the first instance. The clinic was launched on 22 July 2019. Results: Between 22 July 2019
and 31 October 2019, 68 patients seen in the emergency departments (EDs) with palpitations or
pre-syncope were referred to SPACC. Of those, 30 were male and 38 were female, and the mean
age was 45.8 years old (SD 15.1) with a range from 18 years old to 80 years old. A total of 50 (74%)
patients underwent full investigation. On the first assessment, seven (10%) patients were deemed to
have non-cardiac palpitations and were not fitted with the device. All patients who underwent full
investigation achieved symptomatic rhythm correlation most with sinus rhythm, ventricular ectopics,
or bigeminy. A symptomatic cardiac dysrhythmia was detected in six (8.8%) patients. Three patients
had supraventricular tachycardia (4%), two had atrial fibrillation (3%), and one had atrial flutter (2%).
Qualitative feedback from the SPACC team suggested several areas where improvement to the clinic
could be made. Conclusion: We believe a smartphone palpitation service based on ambulatory care is
simple to implement and is effective at detecting cardiac dysrhythmia in ED palpitation patients.
Keywords: emergency department; diagnosis; ECG monitoring; cardiac dysrhythmias
1. Introduction
Patients with palpitations and pre-syncope commonly present to emergency depart-
ments (EDs), accounting for 300,000 ED presentations a year in the United Kingdom [1,2]
and being one of the commonest presentations to general and family practice (16% of
presentations) [3].
Diagnosing the underlying rhythm can be difficult and is commonly not possible dur-
ing the ED visit. Diagnosis of the underlying heart rhythm requires an electrocardiogram
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(ECG) to be recorded while the patient is symptomatic. However, 12-lead ECG is of limited
efficacy and conventional ambulatory monitoring such as Holter has a diagnostic yield of
less than 20% mainly due to the infrequency of symptoms [4].
The AliveCor/Kardia mobile technology is a Food and Drug Administration (FDA)
cleared, CE (Conformitè Europëenne) marked single-lead rhythm strip comparable to
lead I of standard ECG machines and is the most clinically validated ambulatory ECG
device available worldwide. When used alongside the Kardia app, the device provides
instant analysis for normal sinus rhythm, atrial fibrillation, sinus bradycardia, and sinus
tachycardia in around 30 s [5].
The Investigation of Palpitations in the ED (IPED) study [6] was a multi-centre, open-
label, and randomised controlled trial. A total of 243 adults (≥16 years old) presenting
to 10 United Kingdom (UK) hospital EDs were randomised over an 18-month period to
either (a) an intervention group receiving standard care alongside a smartphone-based
event recorder or (b) a control group receiving standard care alone. The primary endpoint
was the detection of a symptomatic rhythm at 90 days.
The results showed that the AliveCor/Kardia smartphone-based event recorder in-
creased the number of patients recording an ECG during symptoms (symptomatic rhythm)
over five-fold at 90 days (69/124; 55.6%; 95% Confidence Interval (CI) 46.9–64.4% versus
11/116; 9.5%; 95% CI 4.2–14.8%; Relative Risk (RR) 5.9, 95% CI 3.3–10.5; p < 0.0001). The
mean time to detecting a symptomatic rhythm in the intervention group was 9.5 days (SD
16.1, range 0–83) compared to 42.9 days (SD 16.0, range 12–66; p < 0.0001) in the control
group. Sinus rhythm, sinus tachycardia, and ectopic beats were the commonest symp-
tomatic rhythms detected. A symptomatic cardiac dysrhythmia was detected at 90 days in
11 (n = 124; 8.9%; 95% CI 3.9–13.9%) participants in the intervention group compared to one
(n = 116; 0.9%; 95% CI 0.0–2.5%) in the control group (RR 10.3, 95% CI 1.3–78.5; p = 0.006).
The IPED study concluded that the use of a smartphone-based event recorder such
as AliveCor/Kardia is safe, non-invasive, and easy to use and should be considered for
all patients presenting acutely to ED with unexplained palpitations or pre-syncope. This
study reports the subsequent establishment of a smartphone palpitation and pre-syncope
ambulatory care clinic (SPACC).
2. Materials and Methods
A clinical standard operating procedure (SOP) was devised, and funding was secured
through a business case for the purchase of 40 AliveCor devices in the first instance which
are able to be cleaned and reused multiple times. From 22 July 2019, all patients aged
16 years or older presenting to the ED or Acute Medicine Unit (AMU) of the Royal Infirmary
of Edinburgh (RIE) with palpitations or pre-syncope, whose ECG was normal, who had a
compatible Apple/android phone, tablet, or watch, and in whom an underlying cardiac
dysrhythmia was possible, were offered an appointment at the SPACC, which was based
in an ambulatory care clinic setting beside the ED. Ambulatory care is a service which
offers same or next-day, hospital-based emergency and acute care, meaning that patients
are assessed, diagnosed, treated, and are able to go home without being admitted into a
hospital bed overnight wherever possible.
Exclusion criteria included the patient being non-ambulant, requiring hospital admis-
sion, having a prior diagnostic ECG, having multiple frequent episodes or recent acute
myocardial infarction (AMI), severe heart failure, or unstable angina, having associated
chest pain or syncope, being unwilling or unable to use the AliveCor Heart Monitor and
ECG App, having a cardiac pacemaker or other implanted electronic device, or having a
likely non-cardiac cause for their palpitations (e.g., anxiety, sepsis).
The patient’s phone, tablet, or watch was checked for compatibility, and they were
asked to bring their smartphone, tablet, or watch and app store password to the ambulatory
appointment (and later were asked to download the Kardia app prior to coming to the
clinic but not to set it up, which was done in the clinic). Routine blood tests including
thyroid function tests, full (complete) blood count, urea and electrolytes, and magnesium
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levels were taken, and the patient was then discharged with a patient advice leaflet to be
seen in the SPACC on the next available day. Initially, only ED and AMU referrals were
taken. The IPED study [6,7] showed that 93% of participants recording a symptomatic
rhythm during the 90 days, did so in the first 28 days. It was therefore decided that patients
would be reviewed at four weeks to enable efficient device usage and timely treatment.
Patients without a symptomatic rhythm at four weeks could be re-reviewed if necessary.
Other components of the SPACC SOP were a list of compatible devices for the
ED/AMU clinician to refer to, a patient symptom diary, a patient instruction manual,
a clinic checklist, and advice for the clinic clinician on how to incorporate a patient ECG
into the RIE electronic patient record (EPR). We also sought approval from our hospital data
controller (termed Caldicott Guardian) who suggested using anonymised patient informa-
tion, standardised for all patients, in the Kardia application (i.e., first name ‘ambulatory’,
last name ‘care’, date of birth ‘01/01/1980′). The local ethics service deemed the study to be
a service evaluation and therefore formal ethical approval was not required. The study was
registered on the RIE ED Quality Improvement Project (QIP) database. A data template
was created using REDCap, a secure electronic database (http://www.project-redcap.org
(accessed on 3 January 2021)) for anonymised data entry, [8,9] which was funded by a grant
from the Royal College of Emergency Medicine (RCEM).
3. Results
Between 22 July 2019 and 31 October 2019, 68 patients were seen in the ED with
palpitations or pre-syncope and were referred to SPACC. Table 1 details their baseline
characteristics. Of those, 30 were male and 38 were female, and the mean age was 45.8 years
old (SD 15.1) with a range from 18 years old to 80 years old. Figure 1 details the flow of
patients through the SPACC. A total of 50 (74%) patients underwent full investigation. On
the first assessment, seven (10%) patients were deemed to have non-cardiac palpitations
and were not fitted with the device. A symptomatic cardiac dysrhythmia was detected in six
(8.8%) patients. Three patients had supraventricular tachycardia (SVT; 4%), two had atrial
fibrillation (3%), and one had atrial flutter (2%). All other patients undergoing investigation
had a non-cardiac symptomatic rhythm detected during their SPACC investigation period
with sinus rhythm, ventricular ectopics, and bigeminy being detected.
Table 1. Baseline characteristics of patients referred to smartphone palpitation and pre-syncope
ambulatory care clinic (SPACC) (n = 68).
Characteristic n (%) Unless Specified Otherwise
Gender Male 30 (44.1%), Female 38 (55.9%)
Age 45.8 (SD 15.1)
Predominant presenting symptom
Fluttering or racing 38 (55.9%)
Chest pain or pressure 9 (13.2%)




Arm or neck pain/tingling 2 (2.9%)
Dizziness 2 (2.9%)
Irregular beating 2 (2.9%)
Presenting symptom duration
1 min or less 5 (7.4%
10 min or less 21 (30.9%)
1 h or less 26 (38.2%)
More than 1 h 16 (23.5%)
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Figure 1. Flowchart of patients through the smartphone palpitation and pre-syncope ambulatory
care clinic (SPACC); ED = Emergency Department; DNA = Did not attend; F/U = Follow up.
Difficulties Addressed and Improvements Made
Clinic referral criteria—qualitative feedback from the SPACC team suggested several
areas where improvement to the service could be made. Firstly, it was noted that 10% of
patients referred to the clinic were deemed on the first assessment to have non-cardiac
pa pitations nd were not fit ed with the device. A pre-plann d sub-study of the IPED
tudy [10] asked th treating ED clini ian to rate th likelihood of u derlying cardiac dys-
rhythmia anging from 1 (least lik ly) to 10 (most likely). An ED clinician likelihoo rating
of 5 r more had 92% sensitivity and 59% specificity for pr icting cardiac dysrhythmia.
This sub-study concluded that ED li icians are able to predict the likelihood of c rdiac
d srhythmia in patients presenting to the ED with palpitatio or pre-syncope wit reason-
able accuracy. It was therefore decided to review the SPACC referral criteria to ensure the
clinic slots were prioritised for patients ‘thought to be at risk of cardiac ysrhythmia’.
Patients expectations—some patients were coming to the SPACC with an expectation
that they were going to be fitted ith the AliveCor device. In order to manage patients’
expectations when the clinic staff might feel that the risk of cardiac dysrhythmia was not
high enough to warrant AliveCor device fitting, the referral pathway was revised to ensure
that patients were counselled in the ED that they were coming to the SPACC for assessment
for AliveCor device fitting.
Embedding of electronic ECGs into the electronic patient record—it was felt that better
embedding of electronic ECGs into the EPR was required. A process and protocol for
uploading ECGs into EPRs were therefore developed.
ECG interpretation—occasionally when the recorded ECG included noise or artefact,
less experienced clinic staff had difficulty interpreting the ECG and would be more likely
to order additional investigations or further AliveCor wear time, whereas more senior
clinicians were comfortable interpreting these recorded ECGs as normal sinus rhythm. It
was therefore encouraged for staff to seek a second opinion from the ED or on-call medical
consultant if required, and an ECG diagnostic algorithm was also developed.
Downloading the Kardia app—due to poor Wi-Fi and phone reception in the SPACC
location, it was decided to alter the referral pathway to ensure patients were asked to
download the Kardia app prior to clinic attendance to increase clinic efficiency.
Length of time between clinic appointments—the median time patients had the device
for was 28 days (Q1, Q3 15.25–30 days). Although the IPED study experience deemed that
this was the optimum time, the SPACC staff felt occasionally that this was too long for
patients who had recorded one of the more symptomatic rhythms within the first week or
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two of having the device. In order to optimise AliveCor device turn over and to counsel
patients who had already recorded a symptomatic rhythm it was decided to bring patients
back earlier at two weeks and if no symptomatic rhythm had been recorded, to allow them
to continue using the device until this had occurred, which for one patient was 76 days.
Other changes to the clinic protocol that were made included less emphasis on patient
diaries which were often poorly completed, better logging of devices, and a routine battery
change for every device every 12 months.
4. Discussion
This is the first report anywhere of an ambulatory smartphone palpitation and pre-
syncope service for emergency and acute medical patients presenting with pre-syncope
and palpitations. The service allows patients who present to either the ED or the AMU of
the RIE with pre-syncope and palpitations to be referred to a next-day assessment clinic for
consideration of AliveCor/Kardia device fitting [11].
Our preliminary three-month clinic data show that the detection of symptomatic
cardiac dysrhythmia in 8.8% of patients is comparable to the 8.9% of patients who had a
symptomatic cardiac dysrhythmia detected in the IPED study [6] and show that a research
protocol and research finding can be successfully extrapolated and implemented in a
pragmatic clinical setting.
We plan to continue to assess our service and to evaluate further the effect of the
changes that were made at the three-month point. Further work could include scaling up
the clinic in order to allow general and family practitioners to refer patients for investigation
and also to integrate the service further with our hospital’s cardiology service. We have also
given support to other health boards across the United Kingdom to help them establish a
similar service and contributed to National Institute for Health and Care Excellence (NICE)
evaluations both in England and Wales of this service model [5,12].
At a time of rapid expansion of health-related applications and smartphone use, this
model of remote monitoring will allow more personalised care and a reduction in the need
for in-hospital care. Bringing back patients to an ambulatory care setting allows assessment
and patient education to take place in a less chaotic environment than in the ED. The
rapid detection of non-life-threatening dysrhythmias such as atrial fibrillation (AF) and
supraventricular tachycardia (SVT) from the ED also potentially reduces ED attendances,
reduces the need for unnecessary cardiology referrals and investigations, allows earlier
prophylactic treatment of those at risk of AF associated cerebrovascular accident (CVA),
and allows earlier treatment of those with symptomatic SVT.
Our service model is generalisable to a wide range of healthcare systems and the
emergency and acute setting and could equally be applied to general and family practitioner
settings for less acute patients. The existence of an AliveCor postal service also allows
hospitals to send out devices which is important during the recent coronavirus disease 2019
(COVID-19) pandemic which is likely to be an ongoing concern in healthcare provision
for at least the next 12 months. This remote option reduces the need for repeat face to face
out-patient clinic attendances and may potentially increase the efficiency of diagnosis and
definitive treatment.
5. Conclusions
We believe a smartphone ambulatory ECG palpitation service is simple to implement
and is effective at detecting cardiac dysrhythmia in emergency and acute palpitation and
pre-syncope patients.
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